In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Adaptive Biotechnologies Corp’s stock clocked out at $7.90, up 0.13% from its previous closing price of $7.89. In other words, the price has increased by $0.13 from its previous closing price. On the day, 0.87 million shares were traded.
Ratios:
To gain a deeper understanding of ADPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 1.04.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 24 ’25 when ROBINS HARLAN S sold 1,698 shares for $9.00 per share. The transaction valued at 15,282 led to the insider holds 1,279,524 shares of the business.
Harlan Robins bought 1,698 shares of ADPT for $14,705 on Mar 24 ’25. On Mar 13 ’25, another insider, GRIFFIN MICHELLE RENEE, who serves as the Director of the company, sold 36,291 shares for $7.19 each. As a result, the insider received 260,932 and left with 15,394 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.56 while its Price-to-Book (P/B) ratio in mrq is 5.76.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $9.01, while it has fallen to a 52-week low of $2.48. The 50-Day Moving Average of the stock is 0.84%, while the 200-Day Moving Average is calculated to be 30.69%.
Shares Statistics:
A total of 147.77M shares are outstanding, with a floating share count of 141.74M. Insiders hold about 4.61% of the company’s shares, while institutions hold 92.05% stake in the company.
